KLEINER PERKINS CAUFIELD & BYERS X B LP
CIK 1128699 · last filed 2014-07-23
KLEINER PERKINS CAUFIELD & BYERS X B LP is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for CDNA, was dated Jul 23, 2014. Across all open-market trades the lifetime net is +$1.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $29.8M across reported positions. The firm reports its address in Menlo Park, CA. 8 SEC filings were submitted jointly with KLEINER PERKINS CAUFIELD & BYERS X A LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CDNA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDNA | 10%+ Owner | 431,270 | $69.10 | $29.80M | $1.58M | 1 | 2014-07-23 |
| ArcSight Inc (ARST) Delisted | 10%+ Owner | 34,047 | — | — | $0 | 3 | 2010-06-28 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 7,264 | — | — | $0 | 1 | 2007-05-03 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-07-23 | CDNA | Mixed | +2,253,522 | $1.58M | EDGAR |
| 2010-06-28 | ArcSight Inc (ARST) Delisted | Other (J) | −11,349 | $0 | EDGAR |
| 2009-06-25 | ArcSight Inc (ARST) Delisted | Other (J) | −11,349 | $0 | EDGAR |
| 2008-02-22 | ArcSight Inc (ARST) Delisted | Conv (C) | +44,200 | $0 | EDGAR |
| 2007-05-03 | Orexigen Therapeutics, Inc. (OREX) Delisted | Conv (C) | +72,642 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.